{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033171","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2026-07-14T20:00:31+00:00","discovered_at":"2026-07-14T20:01:00.291405+00:00","generated_at":"2026-07-14T20:01:07.738078+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncotelic grants 17,796 RSUs to executives tied to exchange uplisting by June 2027","bullets":["17,796 RSUs granted to directors, officers, employees, and advisors; each RSU convertible into 1,000 common shares via Series A Preferred.","CEO Vuong Trieu receives 2,000 RSUs; CMO Anthony Maida and CBO Saran Saund each receive 1,500; CFO Amit Shah receives 1,500.","RSUs vest only if common stock uplists to a national exchange (e.g., Nasdaq, NYSE) on or before June 30, 2027, plus 6 months service.","If uplisting does not occur by June 30, 2027, all RSUs expire; change in control accelerates full vesting.","Potential dilution: up to 17.8 million common shares if all RSUs vest and Preferred converted."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033171","json":"https://secwatch.observer/filing/0001493152-26-033171.json","markdown":"https://secwatch.observer/filing/0001493152-26-033171.md","text":"https://secwatch.observer/filing/0001493152-26-033171.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315226033171/0001493152-26-033171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315226033171/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T20:01:07.738078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}